To do so, they upregulate the expression of TfR, CD91, CD163, Hmox1, FPN, DMT1, and iron-regulated RNA binding proteins (IRP), while downregulating FT expression, which allows for the provision of iron to the tumor cells. The gene discussed is TFRC; the disease is neoplasm.